Ceragenix Pharmaceuticals Receives Frost & Sullivan Product Innovation Award for Cerashield(TM) Coating
August 28, 2007 16:15 ET
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that it is the recipient of Frost & Sullivan's...
Ceragenix Pharmaceuticals Provides Update on EpiCeram(R)
August 22, 2007 08:22 ET
|
Ceragenix Pharmaceuticals
DENVER, Aug 22, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, provided the following update regarding its ongoing...
Ceragenix(TM) Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
July 02, 2007 08:09 ET
|
Ceragenix Pharmaceuticals
DENVER, Jul 2, 2007 -- Ceragenix Pharmaceuticals, Inc. (CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that researchers at the University of...
FDA Grants Ceragenix's Request for Designation
June 12, 2007 08:11 ET
|
Ceragenix Pharmaceuticals
DENVER, Jun 12, 2007 -- Ceragenix Pharmaceuticals, Inc. (CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that the FDA's Office of Combination...
Ceragenix to Present at Rodman & Renshaw Global Healthcare Conference
May 08, 2007 07:56 ET
|
Ceragenix Pharmaceuticals
DENVER, May 8, 2007 -- Ceragenix Pharmaceuticals, Inc. (CGXP), a biopharmaceutical company focused on infectious disease and dermatology, will be presenting at the Acumen BioFion Rodman & Renshaw 4th...
Ceragenix Announces Ceragenins(TM) Virtually Prevent Catheter Biofilm Formation in 21 Day Study
March 12, 2007 09:05 ET
|
Ceragenix Pharmaceuticals
DENVER, Mar 12, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that a catheter treated with a...
Ceragenix Announces Webcast on Use of Ceragenins(TM) as Antimicrobial Coating for Medical Devices and in Contact Lens Disinfectant Solutions
March 08, 2007 08:57 ET
|
Ceragenix Pharmaceuticals
DENVER, March 8, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) a biopharmaceutical company focused on infectious disease and dermatology, today announced that it will conduct a live webcast to...
Ceragenix's New Antibiotic Has Potent Activity Against Vancomycin and Tobramycin Resistant Bacterial Infections
June 28, 2005 08:30 ET
|
Ceragenix Pharmaceuticals
DENVER, June 28, 2005 (PRIMEZONE) -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB:CGXP) today announced that Dr. Paul B. Savage, professor of Chemistry and Biochemistry at...
OnSource Corporation Changes Name to Ceragenix Pharmaceuticals
June 27, 2005 12:46 ET
|
Ceragenix Pharmaceuticals
DENVER, June 27, 2005 (PRIMEZONE) -- OnSource Corporation ("OnSource") has changed its name to Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP). The change in name follows the merger of OnSource with...
Antibiotic Resistant Bacteria A Major Health Threat to Worldwide Population
June 24, 2005 08:49 ET
|
Ceragenix Pharmaceuticals
DENVER, June 24, 2005 (PRIMEZONE) -- The National Foundation for Infectious Disease's annual meeting on Antimicrobial Resistance (NFID) will host experts presenting the latest research in the ongoing...